About VAASAN KESKUSSAIRAALA; Onkologian poliklinikka
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Clinical Trials at VAASAN KESKUSSAIRAALA; Onkologian poliklinikka
During the past decade, VAASAN KESKUSSAIRAALA; Onkologian poliklinikka conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer
2018-12-19
2022-10-12
Completed
160
A Study Of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer.
2019-11-25
2023-02-28
Completed
242
A Study to Evaluate Participant and Healthcare Professional Reported Preference for Subcutaneous Atezolizumab Compared With Intravenous Atezolizumab Formulation in Participants With Non-Small Cell Lung Cancer
2022-04-04
2024-07-31
Recruiting
175
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at VAASAN KESKUSSAIRAALA; Onkologian poliklinikka
According to Clinical.Site data, the most researched conditions in "VAASAN KESKUSSAIRAALA; Onkologian poliklinikka" are
"HER2-Positive Early Breast Cancer" (1 trials), "Non-small Cell Lung Cancer" (1 trials) and "Triple-Negative Breast Cancer" (1 trials). Many other conditions were trialed in "VAASAN KESKUSSAIRAALA; Onkologian poliklinikka" in a lesser frequency.
Clinical Trials Intervention Types at VAASAN KESKUSSAIRAALA; Onkologian poliklinikka
Most popular intervention types in "VAASAN KESKUSSAIRAALA; Onkologian poliklinikka" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (2 trials), "Ipatasertib" (1 trials), "Paclitaxel" (1 trials), "Pertuzumab IV" (1 trials) and "Pertuzumab and Trastuzumab Fixed-Dose Combination for Subcutaneous Administration (PH FDC SC)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at VAASAN KESKUSSAIRAALA; Onkologian poliklinikka
The vast majority of trials in "VAASAN KESKUSSAIRAALA; Onkologian poliklinikka" are
3 trials for "All" genders.
Clinical Trials Status at VAASAN KESKUSSAIRAALA; Onkologian poliklinikka
Currently, there are NaN active trials in "VAASAN KESKUSSAIRAALA; Onkologian poliklinikka".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in VAASAN KESKUSSAIRAALA; Onkologian poliklinikka,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in VAASAN KESKUSSAIRAALA; Onkologian poliklinikka, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".